日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

In vitro microbiota model recapitulates and predicts individualised sensitivity to dietary emulsifier.

体外微生物群模型能够重现并预测个体对膳食乳化剂的敏感性

Rytter Héloïse, Naimi Sabrine, Wu Gary, Lewis Jim, Duquesnoy Maeva, Vigué Lucile, Tenaillon Olivier, Belda Eugeni, Vazquez-Gomez Marta, Touly Nina, Arnone Djésia, Hao Fuhua, Ley Ruth E, Clément Karine, Peyrin-Biroulet Laurent, Patterson Andrew D, Gewirtz Andrew T, Chassaing Benoit

Effective in vivo treatment of acute lung injury with helical, amphipathic peptoid mimics of pulmonary surfactant proteins

利用螺旋状两亲性肽类化合物模拟肺表面活性蛋白,有效治疗急性肺损伤

Czyzewski, Ann M; McCaig, Lynda M; Dohm, Michelle T; Broering, Lauren A; Yao, Li-Juan; Brown, Nathan J; Didwania, Maruti K; Lin, Jennifer S; Lewis, Jim F; Veldhuizen, Ruud; Barron, Annelise E

A framework for understanding and generating integrated solutions for residential peak energy demand

一个用于理解和生成住宅高峰能源需求综合解决方案的框架

Buys, Laurie; Vine, Desley; Ledwich, Gerard; Bell, John; Mengersen, Kerrie; Morris, Peter; Lewis, Jim

Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer

谷氨酰胺酶抑制剂 CB-839 对三阴性乳腺癌的抗肿瘤活性

Matt I Gross, Susan D Demo, Jennifer B Dennison, Lijing Chen, Tania Chernov-Rogan, Bindu Goyal, Julie R Janes, Guy J Laidig, Evan R Lewis, Jim Li, Andrew L Mackinnon, Francesco Parlati, Mirna L M Rodriguez, Peter J Shwonek, Eric B Sjogren, Timothy F Stanton, Taotao Wang, Jinfu Yang, Frances Zhao, Ma

GDC-0980 is a novel class I PI3K/mTOR kinase inhibitor with robust activity in cancer models driven by the PI3K pathway

GDC-0980 是一种新型 I 类 PI3K/mTOR 激酶抑制剂,在 PI3K 通路驱动的癌症模型中具有强大的活性

Jeffrey J Wallin, Kyle A Edgar, Jane Guan, Megan Berry, Wei Wei Prior, Leslie Lee, John D Lesnick, Cristina Lewis, Jim Nonomiya, Jodie Pang, Laurent Salphati, Alan G Olivero, Daniel P Sutherlin, Carol O'Brien, Jill M Spoerke, Sonal Patel, Letitia Lensun, Robert Kassees, Leanne Ross, Mark R Lackner,